<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1179" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1179/" /><meta name="ncbi_pagename" content="Mitochondrial Neurogastrointestinal Encephalopathy Disease - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Mitochondrial Neurogastrointestinal Encephalopathy Disease - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Mitochondrial Neurogastrointestinal Encephalopathy Disease" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/01/14" /><meta name="citation_author" content="Michio Hirano" /><meta name="citation_pmid" content="20301358" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1179/" /><meta name="citation_keywords" content="Mitochondrial Neurogastrointestinal Encephalopathy Syndrome" /><meta name="citation_keywords" content="MNGIE Syndrome" /><meta name="citation_keywords" content="Thymidine Phosphorylase Deficiency" /><meta name="citation_keywords" content="MNGIE Syndrome" /><meta name="citation_keywords" content="Thymidine Phosphorylase Deficiency" /><meta name="citation_keywords" content="Mitochondrial Neurogastrointestinal Encephalopathy Syndrome" /><meta name="citation_keywords" content="Thymidine phosphorylase" /><meta name="citation_keywords" content="TYMP" /><meta name="citation_keywords" content="Mitochondrial Neurogastrointestinal Encephalopathy Disease" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Mitochondrial Neurogastrointestinal Encephalopathy Disease" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Michio Hirano" /><meta name="DC.Date" content="2016/01/14" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1179/" /><meta name="description" content="Mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease is characterized by progressive gastrointestinal dysmotility (manifesting as early satiety, nausea, dysphagia, gastroesophageal reflux, postprandial emesis, episodic abdominal pain and/or distention, and diarrhea); cachexia; ptosis/ophthalmoplegia or ophthalmoparesis; leukoencephalopathy; and demyelinating peripheral neuropathy (manifesting as paresthesias (tingling, numbness, and pain) and symmetric and distal weakness more prominently affecting the lower extremities). The order in which manifestations appear is unpredictable. Onset is usually between the first and fifth decades; in about 60% of individuals, symptoms begin before age 20 years." /><meta name="og:title" content="Mitochondrial Neurogastrointestinal Encephalopathy Disease" /><meta name="og:type" content="book" /><meta name="og:description" content="Mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease is characterized by progressive gastrointestinal dysmotility (manifesting as early satiety, nausea, dysphagia, gastroesophageal reflux, postprandial emesis, episodic abdominal pain and/or distention, and diarrhea); cachexia; ptosis/ophthalmoplegia or ophthalmoparesis; leukoencephalopathy; and demyelinating peripheral neuropathy (manifesting as paresthesias (tingling, numbness, and pain) and symmetric and distal weakness more prominently affecting the lower extremities). The order in which manifestations appear is unpredictable. Onset is usually between the first and fifth decades; in about 60% of individuals, symptoms begin before age 20 years." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1179/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/mngie/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1179/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CC9F7E0400C2100000000052D01D8.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1179_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1179_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mt-mpan/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/echs1-def/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1179_"><span class="title" itemprop="name">Mitochondrial Neurogastrointestinal Encephalopathy Disease</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Mitochondrial Neurogastrointestinal Encephalopathy Syndrome, MNGIE Syndrome, Thymidine Phosphorylase Deficiency</div><p class="contrib-group"><span itemprop="author">Michio Hirano</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1179_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1179_ai__"><div class="contrib half_rhythm"><span itemprop="author">Michio Hirano</span>, MD<div class="affiliation small">H Houston Merritt Center<br />Department of Neurology<br />Columbia University Medical Center<br />New York, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.aibmuloc@92hm" class="oemail">ude.aibmuloc@92hm</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 22, 2005</span>; Last Update: <span itemprop="dateModified">January 14, 2016</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="mngie.Summary" itemprop="description"><h2 id="_mngie_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease is characterized by progressive gastrointestinal dysmotility (manifesting as early satiety, nausea, dysphagia, gastroesophageal reflux, postprandial emesis, episodic abdominal pain and/or distention, and diarrhea); cachexia; ptosis/ophthalmoplegia or ophthalmoparesis; leukoencephalopathy; and demyelinating peripheral neuropathy (manifesting as paresthesias (tingling, numbness, and pain) and symmetric and distal weakness more prominently affecting the lower extremities). The order in which manifestations appear is unpredictable. Onset is usually between the first and fifth decades; in about 60% of individuals, symptoms begin before age 20 years.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The clinical diagnosis of MNGIE disease is based on the presence of severe gastrointestinal dysmotility, cachexia, ptosis, external ophthalmoplegia, sensorimotor neuropathy, asymptomatic leukoencephalopathy as observed on brain MRI, and family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance. The diagnosis of MNGIE disease can be established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by detection of one of the following: (1) <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>TYMP</i> (formerly known as <i>ECGF1</i>); (2) markedly reduced levels of thymidine phosphorylase enzyme activity; or (3) elevated plasma concentrations of thymidine and deoxyuridine.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management is primarily supportive and includes attention to swallowing difficulties and airway protection; dromperidone for nausea and vomiting; gastrostomy, and parenteral feeding for nutritional support; antibiotics for intestinal bacterial overgrowth; amitriptyline, nortriptyline, and gabapentin for neuropathic symptoms; specialized schooling arrangements; and physical and occupational therapy.</p><p><i>Prevention of secondary complications:</i> Attention to swallowing abnormalities and diverticulosis, respectively, may help prevent aspiration pneumonia and ruptured diverticula.</p><p><i>Agents/circumstances to avoid:</i> Drugs that interfere with mitochondrial function should be avoided; medications primarily metabolized in the liver should be used with caution.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>MNGIE disease is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes and therefore carry one mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>; heterozygotes are asymptomatic. Unless an individual with MNGIE disease has offspring with either an affected individual or a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, his/her offspring will be obligate heterozygotes for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TYMP</i>. Carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible once the <i>TYMP</i> pathogenic variants in the family are known.</p></div></div><div id="mngie.Diagnosis"><h2 id="_mngie_Diagnosis_">Diagnosis</h2><div id="mngie.Suggestive_Findings"><h3>Suggestive Findings</h3><p>MNGIE (<i>m</i>itochondrial <i>n</i>euro<i>g</i>astro<i>i</i>ntestinal <i>e</i>ncephalopathy) disease <b>is</b>
<b>suggested</b> by the presence of the following clinical findings, neuroimaging, and family history [<a class="bk_pop" href="#mngie.REF.hirano.1994.721">Hirano et al 1994</a>, <a class="bk_pop" href="#mngie.REF.nishino.1999.689">Nishino et al 1999</a>, <a class="bk_pop" href="#mngie.REF.garone.2011.3326">Garone et al 2011</a>]:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Clinical findings</b></div><ul><li class="half_rhythm"><div>Severe gastrointestinal (GI) dysmotility</div></li><li class="half_rhythm"><div>Cachexia</div></li><li class="half_rhythm"><div>Ptosis</div></li><li class="half_rhythm"><div>External ophthalmoplegia</div></li><li class="half_rhythm"><div>Sensorimotor neuropathy (usually mixed axonal and demyelinating)</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>Neuroimaging.</b> Asymptomatic leukoencephalopathy manifest as diffusely abnormal brain white matter (increased FLAIR or T<sub>2</sub>-weighted signal) on brain MRI. Relative sparing of the corpus callosum is reported in some individuals [<a class="bk_pop" href="#mngie.REF.vissing.2002.926">Vissing et al 2002</a>, <a class="bk_pop" href="#mngie.REF.hirano.2004.8">Hirano et al 2004</a>]. (In the absence of leukoencephalopathy, MNGIE disease is very unlikely.)</div><div class="half_rhythm">Note: Although magnetic resonance spectroscopy (MRS) can show increases in lactate within the white matter, it is not a sensitive diagnostic test.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Family history</b> consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance</div></li></ul></div><div id="mngie.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of MNGIE disease <b>is</b>
<b>established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by detection of one of the following: (1) <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>TYMP</i> (formerly known as <i>ECGF1</i>) (<a class="figpopup" href="/books/NBK1179/table/mngie.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figmngieTmoleculargenetictestingusedi" rid-ob="figobmngieTmoleculargenetictestingusedi">Table 1</a>); (2) markedly reduced levels of thymidine phosphorylase enzyme activity; or (3) elevated plasma concentrations of thymidine and deoxyuridine.</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>TYMP</i> is performed first, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>TYMP</i> and other genes of interest (see <a href="#mngie.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, mitochondrial sequencing, and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>TYMP</i>) fails to confirm a diagnosis in an individual with features of MNGIE disease. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene that results in a similar clinical presentation). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="mngie.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE) Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1179/table/mngie.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mngie.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mngie.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_mngie.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_mngie.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_mngie.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>TYMP</i></td><td headers="hd_h_mngie.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_mngie.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%<sup>4</sup></td></tr><tr><td headers="hd_h_mngie.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_mngie.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="mngie.TF.1.1"><p class="no_margin">See <a href="/books/NBK1179/#mngie.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="mngie.TF.1.2"><p class="no_margin">See <a href="#mngie.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="mngie.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="mngie.TF.1.4"><p class="no_margin">Individuals with enzymatically confirmed MNGIE disease [<a class="bk_pop" href="#mngie.REF.nishino.1999.689">Nishino et al 1999</a>, <a class="bk_pop" href="#mngie.REF.nishino.2000.792">Nishino et al 2000</a>, <a class="bk_pop" href="#mngie.REF.garone.2011.3326">Garone et al 2011</a>]</p></div></dd><dt>5. </dt><dd><div id="mngie.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="mngie.TF.1.6"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div><p><b>Thymidine phosphorylase enzyme (E.C.2.4.2.4) activity</b> in buffy coat in individuals with MNGIE disease that is &#x0003c;8% of the control mean is sufficient to diagnose the disease; however, in late-onset MNGIE disease buffy coat TP activity is less severely diminished (e.g., &#x0003c;18% of the control mean) [<a class="bk_pop" href="#mngie.REF.nishino.1999.689">Nishino et al 1999</a>, <a class="bk_pop" href="#mngie.REF.mart_.2004.120">Mart&#x000ed; et al 2004</a>].</p><p><b>Plasma concentrations of thymidine and deoxyuridine.</b> Increase in plasma thymidine concentration &#x0003e;3 &#x000b5;mol/L or increase in plasma deoxyuridine concentration &#x0003e;5 &#x000b5;mol/L is sufficient to make the diagnosis of MNGIE disease [<a class="bk_pop" href="#mngie.REF.mart_.2004.120">Mart&#x000ed; et al 2004</a>].</p></div></div><div id="mngie.Clinical_Characteristics"><h2 id="_mngie_Clinical_Characteristics_">Clinical Characteristics</h2><div id="mngie.Clinical_Description"><h3>Clinical Description</h3><p>MNGIE disease is characterized by the following major manifestations: gastrointestinal dysmotility, cachexia, progressive external ophthalmoplegia with or without ptosis, peripheral neuropathy, and leukoencephalopathy.</p><p>Gestation and delivery are normal. The earliest reported age of onset is five months; onset is usually between the first and fifth decades. In about 60% of individuals, symptoms begin before age 20 years (mean age at onset: 18 years) [<a class="bk_pop" href="#mngie.REF.garone.2011.3326">Garone et al 2011</a>].</p><p>Prior to the onset of symptoms, many individuals with MNGIE disease are healthy, but usually have a long history of subtle fatigability, mild gastrointestinal symptoms, or thin body habitus.</p><p>The order in which manifestations appear is unpredictable; however, in a review of 102 patients, the first symptoms were gastrointestinal (~57%), ptosis/ophthalmoplegia (~19%), peripheral neuropathy (~14%), and myopathy (~5%) [<a class="bk_pop" href="#mngie.REF.garone.2011.3326">Garone et al 2011</a>].</p><p>Late-onset MNGIE disease occurs in individuals harboring pathogenic <i>TYMP</i> variants that produce less severe thymidine phosphorylase dysfunction [<a class="bk_pop" href="#mngie.REF.mart_.2005.649">Mart&#x000ed; et al 2005</a>].</p><p><b>Gastrointestinal dysmotility and cachexia.</b> Progressive GI dysmotility, caused primarily by enteric myopathy, occurs in virtually all individuals with MNGIE disease at some point during the course of the illness [<a class="bk_pop" href="#mngie.REF.giordano.2008.1120">Giordano et al 2008</a>]. Symptoms usually progress slowly over several decades and can affect any part of the GI tract. Gastric and small bowel hypomotility are the most common. Symptoms include early satiety, nausea, dysphagia, gastroesophageal reflux, postprandial emesis, episodic abdominal pain, episodic abdominal distention, and diarrhea.</p><p>Weight loss and cachexia coincide with the onset of GI symptoms. The average weight loss is about 15 kg [<a class="bk_pop" href="#mngie.REF.nishino.2000.792">Nishino et al 2000</a>]. Affected individuals invariably have a thin body habitus and reduced muscle mass. Despite severe GI dysfunction, serum concentrations of micronutrients, vitamins E and B<sub>12</sub>, and folate are typically normal.</p><p><b>Histologic findings.</b> Rectal biopsy can show eosinophilic cytoplasmic inclusions, representing abnormal mitochondria, in the submucosal ganglion cells [<a class="bk_pop" href="#mngie.REF.perezatayde.1998.1141">Perez-Atayde et al 1998</a>].</p><p>Duodenal pathology can demonstrate focal muscle atrophy or absence with increased nerve numbers, serosal granulomas, and focal loss of Auerbach's plexus with fibrosis [<a class="bk_pop" href="#mngie.REF.teitelbaum.2002.377">Teitelbaum et al 2002</a>].</p><p>Mitochondrial DNA depletion, mitochondrial proliferation, and smooth cell atrophy are observed in the external layer of the muscularis propria in the stomach and in the small intestine [<a class="bk_pop" href="#mngie.REF.giordano.2006.893">Giordano et al 2006</a>, <a class="bk_pop" href="#mngie.REF.giordano.2008.1120">Giordano et al 2008</a>].</p><p>Loss of the pacemaker cells that stimulate gut contraction (interstitial cells of Cajal) is also noted in the small bowel [<a class="bk_pop" href="#mngie.REF.zimmer.2009.627">Zimmer et al 2009</a>].</p><p><b>Eye findings.</b> Ptosis and ophthalmoplegia (weakness of the extraocular muscles) or ophthalmoparesis (lack of function of the extraocular muscles) are common findings. Because of the absence of symptoms like diplopia, individuals with MNGIE disease are often unaware of the eye movement defect. Instead, the abnormalities are usually first noted by a health care provider.</p><p><b>Sensorimotor neuropathy.</b> All individuals with MNGIE disease have peripheral neuropathy. The neuropathy is demyelinating in all cases and about half also have axonal neuropathy. In some, the first symptoms are paresthesias and weakness. Paresthesias occur in a stocking-glove distribution and may be described as tingling, numbness, or even pain. The weakness is usually symmetric and distal. Lower extremities are more prominently <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> than upper extremities. Unilateral or bilateral foot drop, as well as clawed hands, may occur. The severity of the neuropathic symptoms often fluctuates during the early stages of the disease.</p><p>The segmental demyelination is hypothesized to be caused by the uneven distribution of mtDNA abnormalities (depletion, single-nucleotide variants, deletions, duplications) along the nerve. Areas with the highest concentration of these pathogenic variants may be predisposed to demyelination.</p><p>Electrodiagnostic features can include decreased motor and sensory nerve conduction velocities, prolonged F-wave latency, and partial conduction block. Myopathic changes are common.</p><p>Histologically, demyelination and remyelination (onion bulb formation) are observed. Loss of large myelinated fibers is common.</p><p><b>Leukoencephalopathy.</b> The leukoencephalopathy is usually asymptomatic. Spasticity is not present. Although intellectual disability is described in some individuals, dementia can be a rare late feature of the disease [<a class="bk_pop" href="#mngie.REF.carodartal.2007.581">Carod-Artal et al 2007</a>].</p><p><b>Other highly variable clinical manifestations</b></p><ul><li class="half_rhythm"><div>Active hepatic cirrhosis with increased liver enzymes and macrovesicular steatosis</div></li><li class="half_rhythm"><div>Anemia</div></li><li class="half_rhythm"><div>Early-onset sensorineural hearing loss involving either the cochlea or eighth cranial nerve.</div></li><li class="half_rhythm"><div>Diverticula, which may become infected (diverticulitis) or perforate, causing peritonitis, which may be fatal.</div></li><li class="half_rhythm"><div>Hypergonadotropic hypogonadism [<a class="bk_pop" href="#mngie.REF.kalkan.2012.377">Kalkan et al 2012</a>] and hypogonadotropic hypogonadism [<a class="bk_pop" href="#mngie.REF.carodartal.2007.581">Carod-Artal et al 2007</a>] have been reported in isolated patients.</div></li></ul><p><b>Prognosis.</b> MNGIE disease is a progressive, degenerative disease with a poor prognosis. In the study of <a class="bk_pop" href="#mngie.REF.garone.2011.3326">Garone et al [2011]</a>, the mean age of death was 35 years (range 15-54 years).</p><p><b>Other laboratory findings</b></p><ul><li class="half_rhythm"><div>Significantly increased CSF protein (typically 60 - &#x0003e;100 mg/dL; normal: 15 - 45 mg/dL)</div></li><li class="half_rhythm"><div>Lactic acidemia (increased serum concentration of lactate without a change in the pH) and hyperalaninemia are common. Lactic acidosis (increased serum lactate concentration associated with a decrease in blood pH) is unusual, but is more likely to occur in the presence of renal or hepatic impairment.</div></li><li class="half_rhythm"><div>Evidence of mitochondrial dysfunction manifest by any of the following:</div><ul><li class="half_rhythm"><div class="half_rhythm">Histologic abnormalities of a mitochondrial myopathy including ragged-red fibers (Gomori trichrome) and defects in single or multiple OXPHOS enzyme complexes. The most common defect is in cytochrome <i>c</i> oxidase (complex IV).</div><div class="half_rhythm">Note: Normal muscle histopathology can be observed [<a class="bk_pop" href="#mngie.REF.szigeti.2004.125">Szigeti et al 2004</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Acquired mitochondrial DNA (mtDNA) deletions/duplications detected in any tissue by <a class="def" href="/books/n/gene/glossary/def-item/southern-blot/">Southern blot</a> analysis and long-range <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a></div></li><li class="half_rhythm"><div class="half_rhythm">Mitochondrial DNA depletion detected by quantitation of mtDNA relative to nuclear DNA</div></li><li class="half_rhythm"><div class="half_rhythm">Site-specific mtDNA single-nucleotide variants detected in blood and tissues</div></li><li class="half_rhythm"><div class="half_rhythm">Other metabolic abnormalities including increased urine concentrations of deoxyuridine and thymidine. These compounds are not detectable in controls or in individuals who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>TYMP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#mngie.REF.fairbanks.2002.603">Fairbanks et al 2002</a>, <a class="bk_pop" href="#mngie.REF.spinazzola.2002.4128">Spinazzola et al 2002</a>, <a class="bk_pop" href="#mngie.REF.mart_.2003.14">Mart&#x000ed; et al 2003</a>, <a class="bk_pop" href="#mngie.REF.nishigaki.2003.1913">Nishigaki et al 2003</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Post-mortem increases in nucleosides in all tissues [<a class="bk_pop" href="#mngie.REF.valentino.2007.3410">Valentino et al 2007</a>]</div></li></ul></li></ul></div><div id="mngie.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Late-onset disease occurs in individuals harboring <i>TYMP</i> pathogenic variants that produce less severe thymidine phosphorylase dysfunction, such as the c.622G&#x0003e;A variant (p.Val208Met), identified in two of four patients [<a class="bk_pop" href="#mngie.REF.mart_.2005.649">Mart&#x000ed; et al 2005</a>, <a class="bk_pop" href="#mngie.REF.massa.2009.837">Massa et al 2009</a>].</p></div><div id="mngie.Nomenclature"><h3>Nomenclature</h3><p>MNGIE disease was first described as <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> oculo-skeletal myopathy with abnormal muscle and liver mitochondria. Other names for MNGIE disease include polyneuropathy, ophthalmoplegia, leukoencephalopathy, and intestinal pseudo-obstruction (POLIP); oculogastrointestinal muscular dystrophy (OGIMD); and mitochondrial myopathy with sensorimotor polyneuropathy, ophthalmoplegia, and pseudo-obstruction (MEPOP).</p></div><div id="mngie.Prevalence"><h3>Prevalence</h3><p>MNGIE disease is rare. The prevalence is unknown. More than 120 individuals with features consistent with MNGIE disease have been reported since it was first described.</p><p>No ethnic predilection for MNGIE disease has been observed; it occurs in individuals of mixed European, Turkish, Puerto Rican, <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a>, Iranian Jewish, German American, Asian, Spanish, and African American heritage.</p><p>Parental <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> is common, occurring in nearly half the families in some reports [<a class="bk_pop" href="#mngie.REF.nishino.1999.689">Nishino et al 1999</a>, <a class="bk_pop" href="#mngie.REF.nishino.2000.792">Nishino et al 2000</a>].</p></div></div><div id="mngie.Genetically_Related_Allelic_Disord"><h2 id="_mngie_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>TYMP</i>.</p></div><div id="mngie.Differential_Diagnosis"><h2 id="_mngie_Differential_Diagnosis_">Differential Diagnosis</h2><p>MNGIE (<i>m</i>itochondrial <i>n</i>euro<i>g</i>astro<i>i</i>ntestinal <i>e</i>ncephalopathy) disease has been confused with anorexia nervosa and other classes of GI diseases such as intestinal pseudo-obstruction (e.g., <a href="/books/n/gene/actg2-dis/"><i>ACTG2</i>-related disorders</a>), inflammatory bowel disease, <a href="/books/n/gene/celiac/">celiac disease</a>, and irritable bowel disease. Acute abdominal pain in individuals with MNGIE disease has been misdiagnosed as superior mesenteric artery syndrome.</p><p>Because of the rapid appearance of neuropathic symptoms over several months in some individuals, chronic inflammatory demyelinating polyneuropathy (CIDP) has been misdiagnosed [<a class="bk_pop" href="#mngie.REF.bedlack.2004.364">Bedlack et al 2004</a>, <a class="bk_pop" href="#mngie.REF.said.2005.655">Said et al 2005</a>].</p><p><b>Oxidative phosphorylation (OXPHOS) diseases.</b> Because of the cumulative effects on cells of mtDNA depletion and increasing levels of mtDNA deletions and single-nucleotide variants (SNVs) in MNGIE disease, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals present with clinical and metabolic features of oxidative phosphorylation diseases, which are characterized by GI dysmotility, polyneuropathy, and leukoencephalopathy (see <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a> and <a href="http://www.omim.org/phenotypicSeries/PS603041" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mitochondrial DNA depletion syndrome: OMIM Phenotypic Series</a>, to view genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM).</p><p>However, when the diagnostic criteria for MNGIE disease are strictly applied, thymidine phosphorylase activity and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>TYMP</i> are found to be normal in these other disorders [<a class="bk_pop" href="#mngie.REF.vissing.2002.926">Vissing et al 2002</a>, <a class="bk_pop" href="#mngie.REF.hirano.2004.8">Hirano et al 2004</a>].</p><p><b>Disorders caused by imbalance in the mitochondrial nucleotide pools or by quantitative or qualitative defects in mtDNA</b></p><ul><li class="half_rhythm"><div>Autosomal dominant progressive external ophthalmoplegia, caused by:</div><ul><li class="half_rhythm"><div>Mutation of <i>SLC25A4</i> ( previously known as <i>ANT1)</i> (OMIM <a href="http://omim.org/entry/609283" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609283</a>), the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding the heart/skeletal muscle isoform of adenine nucleotide translocator [<a class="bk_pop" href="#mngie.REF.kaukonen.2000.782">Kaukonen et al 2000</a>];</div></li><li class="half_rhythm"><div>Mutation of <i>TWNK</i> (formerly <i>C10orf2</i>) (OMIM <a href="http://omim.org/entry/609286" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609286</a>)<i>,</i> the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding twinkle, a mitochondrial DNA helicase required for mtDNA integrity [<a class="bk_pop" href="#mngie.REF.spelbrink.2001.223">Spelbrink et al 2001</a>];</div></li><li class="half_rhythm"><div>Mutation of <i>POLG</i> or <i>POLG2</i> (see <a href="/books/n/gene/alpers/"><i>POLG</i>-Related Disorders</a>), the genes encoding the two subunits of DNA polymerase gamma, which is responsible for mtDNA replication [<a class="bk_pop" href="#mngie.REF.van_goethem.2001.211">Van Goethem et al 2001</a>];</div></li><li class="half_rhythm"><div>Mutation of <i>RRM2B</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding the small subunit of p53-inducible ribonucleotide reductase (see <a href="/books/n/gene/rrm2b-mtddepl/"><i>RRM2B</i>-Related Mitochondrial Disease</a>).</div></li></ul></li><li class="half_rhythm"><div><a href="/books/n/gene/kss/">Kearns-Sayre syndrome/chronic progressive external ophthalmoplegia</a>, caused by <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> mtDNA deletions/duplications</div></li><li class="half_rhythm"><div>A larger array of mtDNA diseases caused by single-nucleotide variants (SNVs) (For reviews see <a class="bk_pop" href="#mngie.REF.schon.2012.878">Schon et al [2012]</a> and <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>.)</div></li><li class="half_rhythm"><div>Mitochondrial myopathy with mtDNA depletion caused by pathogenic variants in <i>TK2</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding thymidine kinase [<a class="bk_pop" href="#mngie.REF.saada.2001.342">Saada et al 2001</a>] (See <a href="/books/n/gene/tk2-mtddepl/"><i>TK2</i>-Related Mitochondrial DNA Depletion Syndrome, Myopathic Form</a>.)</div></li><li class="half_rhythm"><div>Mitochondrial hepatopathy and encephalopathy with mtDNA depletion caused by pathogenic variants in <i>DGUOK</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding deoxyguanosine kinase [<a class="bk_pop" href="#mngie.REF.mandel.2001.337">Mandel et al 2001</a>] or in <i>MPV17</i>, the gene encoding a mitochondrial inner membrane protein necessary for mtDNA maintenance [<a class="bk_pop" href="#mngie.REF.spinazzola.2006.570">Spinazzola et al 2006</a>] (See <a href="/books/n/gene/dguok-mtddepl/"><i>DGUOK</i>-Related Mitochondrial DNA Depletion Syndrome, Hepatocerebral Form</a> and <a href="/books/n/gene/mpv17-mtdep/"><i>MPV17</i>-related Hepatocerebral Mitochondrial DNA Depletion Syndrome</a>.)</div></li><li class="half_rhythm"><div>Multisystemic diseases with mtDNA depletion caused by mutation of:</div><ul><li class="half_rhythm"><div><i>RRM2B</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding the small subunit of p53-inducible ribonucleotide reductase (see <a href="/books/n/gene/rrm2b-mtddepl/"><i>RRM2B</i>-Related Mitochondrial Disease</a>);</div></li><li class="half_rhythm"><div><i>SUCLA2</i>, encoding succinyl-CoA ligase, ADP-forming, beta subunit (see <a href="/books/n/gene/sucla2-def/"><i>SUCLA2</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Mild Methylmalonic Aciduria</a>);</div></li><li class="half_rhythm"><div><i>SUCLG2</i>, encoding the succinyl-CoA ligase, GDP-forming, beta subunit;</div></li><li class="half_rhythm"><div><i>MGME1,</i> encoding a protein required for mtDNA synthesis [<a class="bk_pop" href="#mngie.REF.kornblum.2013.214">Kornblum et al 2013</a>].</div></li></ul></li></ul><p><b>Leukodystrophy.</b> Various leukodystrophies are distinguished from MNGIE disease by clinical features. These include <a href="/books/n/gene/mld/">metachromatic leukodystrophy</a>, <a href="/books/n/gene/x-ald/">X-linked adrenoleukodystrophy</a>, <a href="/books/n/gene/cach/">childhood ataxia with central nervous system hypomyelination/vanishing white matter disease</a>, <i>GJA12</i> (connexin 46.6) pathogenic variants, <a href="/books/n/gene/pmd/"><i>PLP1</i>-related disorders</a>, <a href="/books/n/gene/krabbe/">Krabbe disease</a>, <a href="/books/n/gene/alexander/">Alexander disease</a>, <a href="/books/n/gene/canavan/">Canavan disease</a>, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy with merosin deficiency (see <a href="/books/n/gene/mdef-cmd/"><i>LAMA2</i>-related muscular dystrophy</a>), and <a href="/books/n/gene/issd/">Salla disease</a>. See also <a href="/books/n/gene/leukodys-ov/">Leukodystrophy Overview</a>.</p><p>Although pathogenic variants in <i>GJB1</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding connexin 32, can be associated with transient white matter defects [<a class="bk_pop" href="#mngie.REF.hanemann.2003.605">Hanemann et al 2003</a>], most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals present with <a href="/books/n/gene/cmtx/">X-linked Charcot-Marie-Tooth disease</a> (CMTX).</p></div><div id="mngie.Management"><h2 id="_mngie_Management_">Management</h2><div id="mngie.Evaluations_at_Initial_Diagnosis"><h3>Evaluations at Initial Diagnosis</h3><p>To establish the extent of disease and needs in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with MNGIE (<i>m</i>itochondrial <i>n</i>euro<i>g</i>astro<i>i</i>ntestinal <i>e</i>ncephalopathy) disease, the following are recommended:</p><ul><li class="half_rhythm"><div>EMG/NCV</div></li><li class="half_rhythm"><div>Brain MRI</div></li><li class="half_rhythm"><div>EKG</div></li><li class="half_rhythm"><div>Ophthalmologic evaluation</div></li><li class="half_rhythm"><div>Audiologic evaluation</div></li><li class="half_rhythm"><div>Assessment of hepatic function, renal function, plasma concentrations of amino acids, and serum concentration of lactate and pyruvate</div></li><li class="half_rhythm"><div>GI evaluation, which depends on the symptoms and may include abdominal films, abdominal CT, upper GI contrast radiography, esophagogastroduodenoscopy, sigmoidoscopy, liquid phase scintigraphy, and antroduodenal manometry. Radiologic studies may show hypoperistalsis, gastroparesis, dilated duodenum, and diverticulosis. Small bowel manometry shows reduced amplitude of contractions.</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="mngie.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Cooperation among multiple specialties including neurology, clinical genetics, nutrition, gastroenterology, pain management, psychiatry, and physical/occupational therapy helps with timely detection and treatment of the various aspects of multiorgan dysfunction. Once symptoms appear, treatment is primarily supportive.</p><p>Management of GI dysfunction can include the following:</p><ul><li class="half_rhythm"><div>Early attention to swallowing difficulties and airway protection, especially in the most severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li><li class="half_rhythm"><div>Trial of dromperidone for nausea and vomiting</div></li><li class="half_rhythm"><div>Nutritional support including (when necessary) bolus feedings, gastrostomy tube placement, and total parenteral nutrition</div></li><li class="half_rhythm"><div>Antibiotic therapy for intestinal bacterial overgrowth, a complication of dysmotility</div></li><li class="half_rhythm"><div>Celiac plexus block with bupivicaine. This has been successful in reducing pain by interrupting visceral afferent pain sensation and increasing GI motility by inhibiting sympathetic efferent activity to the upper abdominal viscera and much of the small bowel [<a class="bk_pop" href="#mngie.REF.teitelbaum.2002.377">Teitelbaum et al 2002</a>]. Splanchnic nerve block has been used successfully to reduce abdominal pain [<a class="bk_pop" href="#mngie.REF.celebi.2006.1073">Celebi et al 2006</a>].</div></li><li class="half_rhythm"><div>Complex medication regimens that include amitriptyline, nortriptyline, and gabapentin for relief of neuropathic symptoms, which are difficult to treat</div></li><li class="half_rhythm"><div>Specialized schooling arrangements, typically necessary for children and young adults</div></li><li class="half_rhythm"><div>Physical therapy and occupational therapy to help preserve mobility. Activity as tolerated should be encouraged.</div></li></ul></div><div id="mngie.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Establishing the correct diagnosis of MNGIE disease may help avoid unnecessary exploratory abdominal surgeries, risks associated with anesthesia, and inappropriate therapies.</p><p>The approximately 20% of individuals with MNGIE disease who have hepatopathy may be at increased risk for worsening hepatic dysfunction caused by medications metabolized by the liver and as a result of total parenteral nutrition. Therefore, medications that are primarily metabolized in the liver should be used with caution.</p><p>Attention to swallowing abnormalities associated with oropharyngeal muscle dysfunction may help decrease the risk for aspiration pneumonia.</p><p>Early attention to diverticulosis can help prevent complications such as ruptured diverticula and fatal peritonitis.</p></div><div id="mngie.Surveillance"><h3>Surveillance</h3><p>Breath test to screen for bacterial overgrowth is recommended.</p><p>Surveillance should be individualized based on symptoms and organs <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p></div><div id="mngie.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid drugs that interfere with mitochondrial function; these include valproate, phenytoin, chloramphenicol, tetracycline, and certain antipsychotic medications [<a class="bk_pop" href="#mngie.REF.shoffner.2008">Shoffner 2008</a>].</p><p>Medications primarily metabolized in the liver should be used with caution [<a class="bk_pop" href="#mngie.REF.finkenstedt.2013.41">Finkenstedt et al 2013</a>].</p></div><div id="mngie.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic or minimally symptomatic older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the <i>TYMP</i> pathogenic variants in the family are known;</div></li><li class="half_rhythm"><div>Measurements of thymidine phosphorylase enzyme (See <a href="#mngie.Establishing_the_Diagnosis">Establishing the Diagnosis</a>, <b>thymidine phosphorylase enzyme</b>) activity or plasma concentrations of thymidine and deoxyuridine (see <a href="#mngie.Establishing_the_Diagnosis">Establishing the Diagnosis</a>, <b>Plasma concentrations of thymidine and deoxyuridine</b>) if the <i>TYMP</i> pathogenic variants in the family are not known.</div></li></ul><p>See <a href="#mngie.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="mngie.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Normalization of intracellular thymidine concentrations could reduce the rate of the mtDNA damage, which progressively increases in an individual over time. Possible future treatments include decreasing plasma thymidine concentration by reducing renal reabsorption of thymidine (i.e., blocking the Na+/thymidine transporter), by dialysis, and by enzyme replacement therapy (ERT).</p><p>Approaches to ERT include allogeneic stem cell transplantation (AHSCT) [<a class="bk_pop" href="#mngie.REF.hirano.2006.1458">Hirano et al 2006</a>, <a class="bk_pop" href="#mngie.REF.rahman.2007.1872">Rahman &#x00026; Hargreaves 2007</a>], carrier erythrocyte entrapped thymidine phosphorylase [<a class="bk_pop" href="#mngie.REF.moran.2008.686">Moran et al 2008</a>], and platelet transfusion.</p><ul><li class="half_rhythm"><div>AHSCT produced nearly full biochemical correction of the deoxythymidine and deoxyuridine imbalances in blood and clinical improvements after successful engraftment of donor cells; however, high morbidity and mortality (16/25 patients died after AHSCT) precludes general use of this therapy for MNGIE disease [<a class="bk_pop" href="#mngie.REF.hirano.2006.1458">Hirano et al 2006</a>, <a class="bk_pop" href="#mngie.REF.halter.2015.2847">Halter et al 2015</a>, <a class="bk_pop" href="#mngie.REF.peedikayil.2015.85">Peedikayil et al 2015</a>].</div></li><li class="half_rhythm"><div>Polymeric enzyme-loaded nanoparticles are being explored for use in MNGIE disease but have not been used in humans [<a class="bk_pop" href="#mngie.REF.de_vocht.2009.246">De Vocht et al 2009</a>].</div></li><li class="half_rhythm"><div>Platelet transfusion produced only transient reductions in blood nucleosides [<a class="bk_pop" href="#mngie.REF.lara.2006.1461">Lara et al 2006</a>].</div></li></ul><p>Search <a href="http://clinicaltrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="mngie.Other"><h3>Other</h3><p>Supplements like coenzyme Q<sub>10</sub>, vitamin K, vitamin C, riboflavin, niacin, and other compounds have no proven efficacy and do not change the natural history of the disease [Shoffner, personal observation].</p><p>Although plasma concentration of thymidine can be reduced by hemodialysis, the plasma concentration becomes elevated again in about three hours [<a class="bk_pop" href="#mngie.REF.spinazzola.2002.4128">Spinazzola et al 2002</a>]. Improvement of symptoms like vomiting and abdominal pain was reported with peritoneal dialysis [<a class="bk_pop" href="#mngie.REF.yavuz.2007.435">Yavuz et al 2007</a>]. No change in blood nucleoside levels was observed.</p></div></div><div id="mngie.Genetic_Counseling"><h2 id="_mngie_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="mngie.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>MNGIE disease is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="mngie.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>TYMP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Unless an individual with MNGIE disease has offspring with either an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual or a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, his/her offspring will be obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TYMP</i>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband's parents is at a 50% risk of being <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>TYMP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="mngie.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p><b>Molecular genetic testing.</b> Carrier detection for at-risk family members requires prior identification of the <i>TYMP</i> pathogenic variants in the family.</p><p><b>Biochemical genetic testing.</b> Although they are unaffected, heterozygotes display about 30%-50% residual thymidine phosphorylase enzyme activity which overlaps with control ranges, and thus cannot be used to determine <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status.</p></div><div id="mngie.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#mngie.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="mngie.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>TYMP</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for MNGIE disease are possible.</p></div></div><div id="mngie.Resources"><h2 id="_mngie_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>United Mitochondrial Disease Foundation (UMDF)</b></div><div>8085 Saltsburg Road</div><div>Suite 201</div><div>Pittsburg PA 15239</div><div><b>Phone:</b> 888-317-8633 (toll-free); 412-793-8077</div><div><b>Fax:</b> 412-793-6477</div><div><b>Email:</b> info@umdf.org</div><div><a href="http://www.umdf.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.umdf.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy UK</b></div><div>61A Great Suffolk Street</div><div>London SE1 0BU </div><div>United Kingdom</div><div><b>Phone:</b> 0800 652 6352 (toll-free); 020 7803 4800</div><div><b>Email:</b> info@musculardystrophyuk.org</div><div><a href="http://www.musculardystrophyuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.musculardystrophyuk.org</a></div></li><li class="half_rhythm"><div><b>RDCRN Patient Contact Registry: North American Mitochondrial Disease Consortium</b></div><div><a href="https://www.rarediseasesnetwork.org/cms/namdc" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Patient Contact Registry</a></div></li></ul></div><div id="mngie.Molecular_Genetics"><h2 id="_mngie_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="mngie.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Mitochondrial Neurogastrointestinal Encephalopathy Disease: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1179/table/mngie.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mngie.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_mngie.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_mngie.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_mngie.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_mngie.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_mngie.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_mngie.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_mngie.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1890" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TYMP</i></a></td><td headers="hd_b_mngie.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1890" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">22q13<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_mngie.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P19971" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Thymidine phosphorylase</a></td><td headers="hd_b_mngie.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/TYMP" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TYMP database</a></td><td headers="hd_b_mngie.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TYMP" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TYMP</a></td><td headers="hd_b_mngie.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TYMP[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TYMP</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="mngie.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="mngie.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Mitochondrial Neurogastrointestinal Encephalopathy Disease (<a href="/omim/131222,603041" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1179/table/mngie.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mngie.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/131222" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">131222</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">THYMIDINE PHOSPHORYLASE; TYMP</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603041" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603041</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1</td></tr></tbody></table></div></div><div id="mngie.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>MNGIE (<i>m</i>itochondrial <i>n</i>euro<i>g</i>astro<i>i</i>ntestinal <i>e</i>ncephalopathy) disease results from the mutagenic effect of thymidine phosphorylase deficiency on mitochondrial DNA (mtDNA). Thymidine phosphorylase deficiency results from pathogenic variants in the nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>TYMP</i>. The pathologic consequences of thymidine phosphorylase deficiency are accumulation of qualitative mtDNA defects (deletions and duplications) and quantitative mtDNA defects (depletion) in various tissues over time. Nuclear DNA damage does not appear to be a factor in the pathogenesis of MNGIE disease.</p><p>In MNGIE disease, increases in deoxythymidine and deoxyuridine with relative deficiency of deoxycytidine cause imbalances in mitochondrial deoxynucleotide 5&#x02019;-triphosphate (dNTP) pools with relative excess of deoxythymidine triphosphate (dTTP) and paucity of deoxycytidine triphosphate (dCTP), producing mtDNA instability [<a class="bk_pop" href="#mngie.REF.nishigaki.2003.1913">Nishigaki et al 2003</a>, <a class="bk_pop" href="#mngie.REF.l_pez.2009.714">L&#x000f3;pez et al 2009</a>, <a class="bk_pop" href="#mngie.REF.garciadiaz.2014.1337">Garcia-Diaz et al 2014</a>]. This preferential damage to mtDNA over time appears to be the result of several factors:</p><ul><li class="half_rhythm"><div>The mitochondrial dNTP pool is sequestered within the mitochondria.</div></li><li class="half_rhythm"><div>Mitochondrial DNA is more dependent on thymidine salvage than nuclear DNA, which depends primarily on <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> thymidine synthesis.</div></li><li class="half_rhythm"><div>Mitochondrial DNA has a limited capability to repair damage as compared to nuclear DNA.</div></li></ul><p>Since mtDNA continues to replicate throughout an individual's life, various tissues throughout the body develop abnormalities over time as a result of progressive oxidative phosphorylation (OXPHOS) impairment. Accumulation of mtDNA pathogenic variants can be observed in fibroblasts and tissues of individuals with MNGIE disease as well in HeLa cells cultured in the presence of increased thymidine [<a class="bk_pop" href="#mngie.REF.nishigaki.2003.1913">Nishigaki et al 2003</a>, <a class="bk_pop" href="#mngie.REF.song.2003.43893">Song et al 2003</a>]. Mitochondrial DNA depletion and mtDNA deletions are present in most individuals with MNGIE disease, but not all [<a class="bk_pop" href="#mngie.REF.hirano.1994.721">Hirano et al 1994</a>, <a class="bk_pop" href="#mngie.REF.debouverie.1997.547">Debouverie et al 1997</a>, <a class="bk_pop" href="#mngie.REF.hamano.1997.917">Hamano et al 1997</a>].</p><p>Thymidine-deficient mice (TP -/-) appear normal and do not show features of MNGIE disease [<a class="bk_pop" href="#mngie.REF.haraguchi.2002.5212">Haraguchi et al 2002</a>]. Since mice can use uridine phosphorylase to clear thymidine, deficiency in both thymidine phosphorylase and uridine phosphorylase are required to affect nucleoside metabolism. Mice that are double mutants for these two enzymes produce increased T<sub>2</sub>-weighted signal on MRI in white matter with partial depletion of mtDNA in brain [<a class="bk_pop" href="#mngie.REF.l_pez.2009.714">L&#x000f3;pez et al 2009</a>]. Oral administration of thymidine and deoxyuridine to the double mutant mice enhances the abnormal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and shortens life span, demonstrating that the nucleosides are toxic to mitochondria [<a class="bk_pop" href="#mngie.REF.garciadiaz.2014.1337">Garcia-Diaz et al 2014</a>].</p><p><b>Gene structure.</b>
<i>TYMP</i> comprises ten exons spanning &#x0003e;4.3 kb [<a class="bk_pop" href="#mngie.REF.hagiwara.1991.2125">Hagiwara et al 1991</a>]. See <a href="/books/NBK1179/bin/mngie-Table2.pdf">Table 2</a> (pdf).</p><p><b>Pathogenic variants.</b> The nucleotide positions listed in the <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA are according to <a class="bk_pop" href="#mngie.REF.hagiwara.1991.2125">Hagiwara et al [1991]</a>. No large deletions involving this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> have been described. Note that the pathogenicity of splice-site variants is confirmed by identification of altered <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> in reverse transcriptase (RT) <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> assays.</p><p>See <a href="/books/NBK1179/bin/mngie-Tables3-7.pdf">Tables 3-7</a> (pdf).</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Thymidine phosphorylase is a homodimer that catalyzes the conversion of thymidine to thymine and 2-deoxy-D-ribose 1-phosphate [<a class="bk_pop" href="#mngie.REF.brown.1998.1">Brown &#x00026; Bicknell 1998</a>]. The forward reaction (thymidine to thymine) is important to nucleoside catabolism. Although the reverse reaction is possible (thymidine to thymidine triphosphate), only the forward reaction appears important physiologically. Thymidine phosphorylase is expressed in the GI system, brain, peripheral nerves, autonomic nerves, spleen, bladder, and lungs and is not expressed in muscle, kidney, gallbladder, aorta, or fat.</p><p>Thymidine phosphorylase was originally mistakenly identified as a "growth factor" abundant in platelets; therefore, it was named "platelet-derived endothelial cell growth factor" (PD-ECGF or ECGF1). The misconception that thymidine phosphorylase (TP) is a growth factor is based on [<sup>3</sup>H]-labeled thymidine incorporation assays. Purified "ECGF" was added to cell culture medium 18 hours prior to addition of [<sup>3</sup>H]-thymidine, which was rapidly incorporated by cultured endothelial cells. This result was misinterpreted as stimulation of mitosis. In reality, the addition of TP degraded thymidine in the culture medium, and subsequently the thymidine-starved endothelial cells rapidly incorporated the [<sup>3</sup>H]-thymidine. TP may be angiogenic indirectly because ribose liberated from the degradation of thymidine may stimulate cell division and migration [<a class="bk_pop" href="#mngie.REF.brown.1998.1">Brown &#x00026; Bicknell 1998</a>]. In addition to its function in angiogenesis, it also limits glial cell proliferation.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> See <a href="#mngie.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</a>.</p></div></div><div id="mngie.References"><h2 id="_mngie_References_">References</h2><div id="mngie.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.bedlack.2004.364">Bedlack RS, Vu T, Hammans S, Sparr SA, Myers B, Morgenlander J, Hirano M. MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy. <span><span class="ref-journal">Muscle Nerve. </span>2004;<span class="ref-vol">29</span>:364–8.</span> [<a href="/pubmed/14981734" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14981734</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.brown.1998.1">Brown NS, Bicknell R. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. <span><span class="ref-journal">Biochem J. </span>1998;<span class="ref-vol">334</span>:1–8.</span> [<a href="/pmc/articles/PMC1219653/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1219653</span></a>] [<a href="/pubmed/9693094" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9693094</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.carodartal.2007.581">Carod-Artal FJ, Herrero MD, Lara MC, Lopez-Gallardo E, Ruiz-Pesini E, Marti R, Montoya J. Cognitive dysfunction and hypogonadotropic hypogonadism in a Brazilian patient with mitochondrial neurogastrointestinal encephalomyopathy and a novel ECGF1 mutation. <span><span class="ref-journal">Eur J Neurol. </span>2007;<span class="ref-vol">14</span>:581–5.</span> [<a href="/pubmed/17437622" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17437622</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.celebi.2006.1073">Celebi N, Sahin A, Canbay O, Uz&#x000fc;mc&#x000fc;gil F, Aypar U. Abdominal pain related to mitochondrial neurogastrointestinal encephalomyopathy syndrome may benefit from splanchnic nerve blockade. <span><span class="ref-journal">Paediatr Anaesth. </span>2006;<span class="ref-vol">16</span>:1073–6.</span> [<a href="/pubmed/16972839" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16972839</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.debouverie.1997.547">Debouverie M, Wagner M, Ducrocq X, Grignon Y, Mousson B, Weber M. <span><span class="ref-journal">Rev Neurol (Paris). </span>1997;<span class="ref-vol">153</span>:547–53.</span> [MNGIE syndrome in 2 siblings] [<a href="/pubmed/9684018" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9684018</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.de_vocht.2009.246">De Vocht C, Ranquin A, Willaert R, Van Ginderachter JA, Vanhaecke T, Rogiers V, Vers&#x000e9;es W, Van Gelder P, Steyaert J. Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE. <span><span class="ref-journal">J Control Release. </span>2009;<span class="ref-vol">137</span>:246–54.</span> [<a href="/pubmed/19371766" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19371766</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.fairbanks.2002.603">Fairbanks LD, Marinaki AM, Carrey EA, Hammans SR, Duley JA. Deoxyuridine accumulation in urine in thymidine phosphorylase deficiency (MNGIE). <span><span class="ref-journal">J Inherit Metab Dis. </span>2002;<span class="ref-vol">25</span>:603–4.</span> [<a href="/pubmed/12638947" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12638947</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.finkenstedt.2013.41">Finkenstedt A, Schranz M, Bosch S, Karall D, Burgi SS, Ensinger C, Drach M, Mayr JA, Janecke AR, Vogel W, Nachbaur D, Zoller H. MNGIE syndrome: Liver cirrhosis should be ruled out prior to bone marrow transplantation. <span><span class="ref-journal">JIMD Reports. </span>2013;<span class="ref-vol">10</span>:41–4.</span> [<a href="/pmc/articles/PMC3755566/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3755566</span></a>] [<a href="/pubmed/23430799" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23430799</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.garciadiaz.2014.1337">Garcia-Diaz B, Garone C, Barca E, Mojahed H, Gutierrez P, Pizzorno G, Tanji K, Arias-Mendoza F, Quinzii CM, Hirano M. Deoxynucleoside stress exacerbates the phenotype of a mouse model of mitochondrial neurogastrointestinal encephalopathy. <span><span class="ref-journal">Brain. </span>2014;<span class="ref-vol">137</span>:1337–49.</span> [<a href="/pmc/articles/PMC3999724/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3999724</span></a>] [<a href="/pubmed/24727567" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24727567</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.garone.2011.3326">Garone C, Tadesse S, Hirano M. Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. <span><span class="ref-journal">Brain. </span>2011;<span class="ref-vol">134</span>:3326–32.</span> [<a href="/pmc/articles/PMC3212717/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3212717</span></a>] [<a href="/pubmed/21933806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21933806</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.giordano.2008.1120">Giordano C, Sebastiani M, De Giorgio R, Travaglini C, Tancredi A, Valentino ML, Bellan M, Cossarizza A, Hirano M, d'Amati G, Carelli V. Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion. <span><span class="ref-journal">Am J Pathol. </span>2008;<span class="ref-vol">173</span>:1120–8.</span> [<a href="/pmc/articles/PMC2543079/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2543079</span></a>] [<a href="/pubmed/18787099" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18787099</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.giordano.2006.893">Giordano C, Sebastiani M, Plazzi G, Travaglini C, Sale P, Pinti M, Tancredi A, Liguori R, Montagna P, Bellan M, Valentino ML, Cossarizza A, Hirano M, d'Amati G, Carelli V. Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine. <span><span class="ref-journal">Gastroenterology. </span>2006;<span class="ref-vol">130</span>:893–901.</span> [<a href="/pubmed/16530527" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16530527</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.hagiwara.1991.2125">Hagiwara K, Stenman G, Honda H, Sahlin P, Andersson A, Miyazono K, Heldin CH, Ishikawa F, Takaku F. Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene. <span><span class="ref-journal">Mol Cell Biol. </span>1991;<span class="ref-vol">11</span>:2125–32.</span> [<a href="/pmc/articles/PMC359900/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC359900</span></a>] [<a href="/pubmed/2005900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2005900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.halter.2015.2847">Halter JP, Michael W, Schupbach M, Mandel H, Casali C, Orchard K, Collin M, Valcarcel D, Rovelli A, Filosto M, Dotti MT, Marotta G, Pintos G, Barba P, Accarino A, Ferra C, Illa I, Beguin Y, Bakker JA, Boelens JJ, de Coo IF, Fay K, Sue CM, Nachbaur D, Zoller H, Sobreira C, Pinto Simoes B, Hammans SR, Savage D, Marti R, Chinnery PF, Elhasid R, Gratwohl A, Hirano M. Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy. <span><span class="ref-journal">Brain. </span>2015;<span class="ref-vol">138</span>:2847–58.</span> [<a href="/pmc/articles/PMC4836400/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4836400</span></a>] [<a href="/pubmed/26264513" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26264513</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.hamano.1997.917">Hamano H, Ohta T, Takekawa Y, Kouda K, Shinohara Y. <span><span class="ref-journal">Rinsho Shinkeigaku. </span>1997;<span class="ref-vol">37</span>:917–22.</span> [Mitochondrial neurogastrointestinal encephalomyopathy presenting with protein-losing gastroenteropathy and serum copper deficiency: a case report] [<a href="/pubmed/9490904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9490904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.hanemann.2003.605">Hanemann CO, Bergmann C, Senderek J, Zerres K, Sperfeld AD. Transient, recurrent, white matter lesions in X-linked Charcot-Marie-Tooth disease with novel connexin 32 mutation. <span><span class="ref-journal">Arch Neurol. </span>2003;<span class="ref-vol">60</span>:605–9.</span> [<a href="/pubmed/12707076" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12707076</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.haraguchi.2002.5212">Haraguchi M, Tsujimoto H, Fukushima M, Higuchi I, Kuribayashi H, Utsumi H, Nakayama A, Hashizume Y, Hirato J, Yoshida H, Hara H, Hamano S, Kawaguchi H, Furukawa T, Miyazono K, Ishikawa F, Toyoshima H, Kaname T, Komatsu M, Chen ZS, Gotanda T, Tachiwada T, Sumizawa T, Miyadera K, Osame M, Yoshida H, Noda T, Yamada Y, Akiyama S. Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice. <span><span class="ref-journal">Mol Cell Biol. </span>2002;<span class="ref-vol">22</span>:5212–21.</span> [<a href="/pmc/articles/PMC139774/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC139774</span></a>] [<a href="/pubmed/12077348" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12077348</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.hirano.2006.1458">Hirano M, Mart&#x000ed; R, Casali C, Tadesse S, Uldrick T, Fine B, Escolar DM, Valentino ML, Nishino I, Hesdorffer C, Schwartz J, Hawks RG, Martone DL, Cairo MS, DiMauro S, Stanzani M, Garvin JH Jr, Savage DG. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:1458–60.</span> [<a href="/pmc/articles/PMC4345106/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4345106</span></a>] [<a href="/pubmed/16971696" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16971696</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.hirano.2004.8">Hirano M, Nishigaki Y, Marti R. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes. <span><span class="ref-journal">Neurologist. </span>2004;<span class="ref-vol">10</span>:8–17.</span> [<a href="/pubmed/14720311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14720311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.hirano.1994.721">Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, Hays AP, Lovelace RE, Butler I, Bertorini TE. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. <span><span class="ref-journal">Neurology. </span>1994;<span class="ref-vol">44</span>:721–7.</span> [<a href="/pubmed/8164833" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8164833</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.kalkan.2012.377">Kalkan IH, Tayfur O, Oztas E, Beyazit Y, Yildiz H, Tunc B. A novel finding in MNGIE (mitochondrial neurogastrointestinal encephalomyopathy): hypergonadotropic hypogonadism. <span><span class="ref-journal">Hormones. </span>2012;<span class="ref-vol">11</span>:377–9.</span> [<a href="/pubmed/22908072" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22908072</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.kaukonen.2000.782">Kaukonen J, Juselius JK, Tiranti V, Kyttala A, Zeviani M, Comi GP, Keranen S, Peltonen L, Suomalainen A. Role of adenine nucleotide translocator 1 in mtDNA maintenance. <span><span class="ref-journal">Science. </span>2000;<span class="ref-vol">289</span>:782–5.</span> [<a href="/pubmed/10926541" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10926541</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.kornblum.2013.214">Kornblum C, Nicholls TJ, Haack TB, Scholer S, Peeva V, Danhauser K, Hallmann K, Zsurka G, Rorbach J, Iuso A, Wieland T, Sciacco M, Ronchi D, Comi GP, Moggio M, Quinzii CM, DiMauro S, Calvo SE, Mootha VK, Klopstock T, Strom TM, Meitinger T, Minczuk M, Kunz WS, Prokisch H. Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:214–9.</span> [<a href="/pmc/articles/PMC3678843/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3678843</span></a>] [<a href="/pubmed/23313956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23313956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.lara.2006.1461">Lara MC, Weiss B, Illa I, Madoz P, Massuet L, Andreu AL, Valentino ML, Anikster Y, Hirano M, Mart&#x000ed; R. Infusion of platelets transiently reduces nucleoside overload in MNGIE. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:1461–3.</span> [<a href="/pubmed/16971699" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16971699</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.l_pez.2009.714">L&#x000f3;pez LC, Akman HO, Garcia-Cazorla A, Dorado B, Marti R, Nishino I, Tadesse S, Pizzorno G, Shungu DC, Bonilla E, Tanji K, Hirano M. Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase deficient mice. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:714–22.</span> [<a href="/pmc/articles/PMC2638828/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2638828</span></a>] [<a href="/pubmed/19028666" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19028666</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.mandel.2001.337">Mandel H, Szargel R, Labay V, Elpeleg O, Saada A, Shalata A, Anbinder Y, Berkowitz D, Hartman C, Barak M, Eriksson S, Cohen N. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">29</span>:337–41.</span> [<a href="/pubmed/11687800" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11687800</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.mart_.2003.14">Mart&#x000ed; R, Nishigaki Y, Hirano M. Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2003;<span class="ref-vol">303</span>:14–8.</span> [<a href="/pubmed/12646159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12646159</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.mart_.2004.120">Mart&#x000ed; R, Spinazzola A, Tadesse S, Nishino I, Nishigaki Y, Hirano M. Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays. <span><span class="ref-journal">Clin Chem. </span>2004;<span class="ref-vol">50</span>:120–4.</span> [<a href="/pubmed/14633909" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14633909</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.mart_.2005.649">Mart&#x000ed; R, Verschuuren JJ, Buchman A, Hirano I, Tadesse S, van Kuilenburg AB, van Gennip AH, Poorthuis BJ, Hirano M. Late-onset MNGIE due to partial loss of thymidine phosphorylase activity. <span><span class="ref-journal">Ann Neurol. </span>2005;<span class="ref-vol">58</span>:649–52.</span> [<a href="/pubmed/16178026" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16178026</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.massa.2009.837">Massa R, Tessa A, Margollicci M, Micheli V, Romigi A, Tozzi G, Terracciano C, Piemonte F, Bernardi G, Santorelli FM. Late-onset MNGIE without peripheral neuropathy due to incomplete loss of thymidine phosphorylase activity. <span><span class="ref-journal">Neuromuscular disorders. </span>2009;<span class="ref-vol">19</span>:837–40.</span> [<a href="/pubmed/19853446" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19853446</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.moran.2008.686">Moran NF, Bain MD, Muqit MM, Bax BE. Carrier erythrocyte entrapped thymidine phosphorylase therapy for MNGIE. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">71</span>:686–8.</span> [<a href="/pubmed/18725595" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18725595</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.nishigaki.2003.1913">Nishigaki Y, Marti R, Copeland WC, Hirano M. Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. <span><span class="ref-journal">J Clin Invest. </span>2003;<span class="ref-vol">111</span>:1913–21.</span> [<a href="/pmc/articles/PMC161426/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC161426</span></a>] [<a href="/pubmed/12813027" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12813027</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.nishino.1999.689">Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. <span><span class="ref-journal">Science. </span>1999;<span class="ref-vol">283</span>:689–92.</span> [<a href="/pubmed/9924029" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9924029</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.nishino.2000.792">Nishino I, Spinazzola A, Papadimitriou A, Hammans S, Steiner I, Hahn CD, Connolly AM, Verloes A, Guimaraes J, Maillard I, Hamano H, Donati MA, Semrad CE, Russell JA, Andreu AL, Hadjigeorgiou GM, Vu TH, Tadesse S, Nygaard TG, Nonaka I, Hirano I, Bonilla E, Rowland LP, DiMauro S, Hirano M. Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. <span><span class="ref-journal">Ann Neurol. </span>2000;<span class="ref-vol">47</span>:792–800.</span> [<a href="/pubmed/10852545" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10852545</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.peedikayil.2015.85">Peedikayil MC, Kagevi EI, Abufarhaneh E, Alsayed MD, Alzahrani HA. Mitochondrial neurogastrointestinal encephalomyopathy treated with stem cell transplantation: a case report and review of literature. <span><span class="ref-journal">Hematol Oncol Stem Cell Ther. </span>2015;<span class="ref-vol">8</span>:85–90.</span> [<a href="/pubmed/25585305" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25585305</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.perezatayde.1998.1141">Perez-Atayde AR, Fox V, Teitelbaum JE, Anthony DA, Fadic R, Kalsner L, Rivkin M, Johns DR, Cox GF. Mitochondrial neurogastrointestinal encephalomyopathy: diagnosis by rectal biopsy. <span><span class="ref-journal">Am J Surg Pathol. </span>1998;<span class="ref-vol">22</span>:1141–7.</span> [<a href="/pubmed/9737248" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9737248</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.rahman.2007.1872">Rahman S, Hargreaves IP. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. <span><span class="ref-journal">Neurology. </span>2007;<span class="ref-vol">68</span>:1872.</span> [<a href="/pubmed/17515557" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17515557</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.saada.2001.342">Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">29</span>:342–4.</span> [<a href="/pubmed/11687801" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11687801</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.said.2005.655">Said G, Lacroix C, Plante-Bordeneuve V, Messing B, Slama A, Crenn P, Nivelon-Chevallier A, Bedenne L, Soichot P, Manceau E, Rigaud D, Guiochon-Mantel A, Matuchansky C. Clinicopathological aspects of the neuropathy of neurogastrointestinal encephalomyopathy (MNGIE) in four patients including two with a Charcot-Marie-Tooth presentation. <span><span class="ref-journal">J Neurol. </span>2005;<span class="ref-vol">252</span>:655–62.</span> [<a href="/pubmed/15742109" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15742109</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.schon.2012.878">Schon EA, DiMauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. <span><span class="ref-journal">Nat Rev Genet. </span>2012;<span class="ref-vol">13</span>:878–90.</span> [<a href="/pmc/articles/PMC3959762/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3959762</span></a>] [<a href="/pubmed/23154810" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23154810</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.shoffner.2008">Shoffner JM. Mitochondrial diseases. MedLink Neurology. San Diego, CA: S Gilman, MedLink Corporation. 2008.</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.spinazzola.2006.570">Spinazzola A, Viscomi C, Fernandez-Vizarra E, Carrara F, D'Adamo P, Calvo S, Marsano RM, Donnini C, Weiher H, Strisciuglio P, Parini R, Sarzi E, Chan A, DiMauro S, Rotig A, Gasparini P, Ferrero I, Mootha VK, Tiranti V, Zeviani M. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:570–5.</span> [<a href="/pubmed/16582910" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16582910</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.song.2003.43893">Song S, Wheeler LJ, Mathews CK. Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:43893–6.</span> [<a href="/pubmed/13679382" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13679382</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.spelbrink.2001.223">Spelbrink JN, Li FY, Tiranti V, Nikali K, Yuan QP, Tariq M, Wanrooij S, Garrido N, Comi G, Morandi L, Santoro L, Toscano A, Fabrizi GM, Somer H, Croxen R, Beeson D, Poulton J, Suomalainen A, Jacobs HT, Zeviani M, Larsson C. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">28</span>:223–31.</span> [<a href="/pubmed/11431692" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11431692</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.spinazzola.2002.4128">Spinazzola A, Marti R, Nishino I, Andreu AL, Naini A, Tadesse S, Pela I, Zammarchi E, Donati MA, Oliver JA, Hirano M. Altered thymidine metabolism due to defects of thymidine phosphorylase. <span><span class="ref-journal">J Biol Chem. </span>2002;<span class="ref-vol">277</span>:4128–33.</span> [<a href="/pubmed/11733540" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11733540</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.szigeti.2004.125">Szigeti K, Wong LJ, Perng CL, Saifi GM, Eldin K, Adesina AM, Cass DL, Hirano M, Lupski JR, Scaglia F. MNGIE with lack of skeletal muscle involvement and a novel TP splice site mutation. <span><span class="ref-journal">J Med Genet. </span>2004;<span class="ref-vol">41</span>:125–9.</span> [<a href="/pmc/articles/PMC1735672/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735672</span></a>] [<a href="/pubmed/14757860" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14757860</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.teitelbaum.2002.377">Teitelbaum JE, Berde CB, Nurko S, Buonomo C, Perez-Atayde AR, Fox VL. Diagnosis and management of MNGIE syndrome in children: case report and review of the literature. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2002;<span class="ref-vol">35</span>:377–83.</span> [<a href="/pubmed/12352533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12352533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.valentino.2007.3410">Valentino ML, Mart&#x000ed; R, Tadesse S, L&#x000f3;pez LC, Manes JL, Lyzak J, Hahn A, Carelli V, Hirano M. Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). <span><span class="ref-journal">FEBS Lett. </span>2007;<span class="ref-vol">581</span>:3410–4.</span> [<a href="/pmc/articles/PMC1986782/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1986782</span></a>] [<a href="/pubmed/17612528" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17612528</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.van_goethem.2001.211">Van Goethem G, Dermaut B, Lofgren A, Martin JJ, Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">28</span>:211–2.</span> [<a href="/pubmed/11431686" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11431686</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.vissing.2002.926">Vissing J, Ravn K, Danielsen ER, Duno M, Wibrand F, Wevers RA, Schwartz M. Multiple mtDNA deletions with features of MNGIE. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">59</span>:926–9.</span> [<a href="/pubmed/12297582" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12297582</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.yavuz.2007.435">Yavuz H, Ozel A, Christensen M, Christensen E, Schwartz M, Elmaci M, Vissing J. Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis. <span><span class="ref-journal">Arch Neurol. </span>2007;<span class="ref-vol">64</span>:435–8.</span> [<a href="/pubmed/17353390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17353390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mngie.REF.zimmer.2009.627">Zimmer V, Feiden W, Becker G, Zimmer A, Reith W, Raedle J, Lammert F, Zeuzem S, Hirano M, Menges M. Absence of the interstitial cell of Cajal network in mitochondrial neurogastrointestinal encephalomyopathy. <span><span class="ref-journal">Neurogastroenterol Motil. </span>2009;<span class="ref-vol">21</span>:627–31.</span> [<a href="/pubmed/19368660" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19368660</span></a>]</div></li></ul></div></div><div id="mngie.Chapter_Notes"><h2 id="_mngie_Chapter_Notes_">Chapter Notes</h2><div id="mngie.Author_History"><h3>Author History</h3><p>Michio Hirano, MD (2016-present)<br />John M Shoffner, MD; Georgia State University (2005-2016)</p></div><div id="mngie.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>14 January 2016 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 May 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 April 2005 (me) Review posted to live Web site</div></li><li class="half_rhythm"><div>16 September 2004 (jms) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1179</span><span class="label">PMID: <a href="/pubmed/20301358" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301358</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mt-mpan/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/echs1-def/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1179&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1179/?report=reader">PubReader</a></li><li><a href="/books/NBK1179/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1179" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1179" style="display:none" title="Cite this Page"><div class="bk_tt">Hirano M. Mitochondrial Neurogastrointestinal Encephalopathy Disease. 2005 Apr 22 [Updated 2016 Jan 14]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1179/pdf/Bookshelf_NBK1179.pdf">PDF version of this page</a> (457K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#mngie.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#mngie.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#mngie.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#mngie.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#mngie.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#mngie.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#mngie.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#mngie.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#mngie.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#mngie.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#mngie.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1890[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TYMP</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5428[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">POLG</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1487538" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1487538" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1487538" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1487538" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24741716" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">RRM2B</i>-Related Mitochondrial Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">RRM2B</i>-Related Mitochondrial Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gorman GS, Taylor RW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27371119" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Mitochondrial Neuro-Gastro-Intestinal Encephalopathy (MNGIE): When and how to suspect it in front of an atypical anorexia nervosa?]</a><span class="source">[Encephale. 2016]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Mitochondrial Neuro-Gastro-Intestinal Encephalopathy (MNGIE): When and how to suspect it in front of an atypical anorexia nervosa?]<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Danjou M, Guardia D, Geoffroy PA, Seguy D, Cottencin O. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Encephale. 2016 Dec; 42(6):574-579. Epub 2016 Jun 28.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301791" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Cohen BH, Chinnery PF, Copeland WC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30373120" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE-MTDPS1).</a><span class="source">[J Clin Med. 2018]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE-MTDPS1).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Filosto M, Cotti Piccinelli S, Caria F, Gallo Cassarino S, Baldelli E, Galvagni A, Volonghi I, Scarpelli M, Padovani A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Clin Med. 2018 Oct 26; 7(11). Epub 2018 Oct 26.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21794876" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Mitochondrial neurogastrointestinal encephalopathy in an Indian family with possible manifesting carriers of heterozygous TYMP mutation.</a><span class="source">[J Neurol Sci. 2011]</span><div class="brieflinkpop offscreen_noflow">Mitochondrial neurogastrointestinal encephalopathy in an Indian family with possible manifesting carriers of heterozygous TYMP mutation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nalini A, Gayathri N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Neurol Sci. 2011 Oct 15; 309(1-2):131-5. Epub 2011 Jul 26.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301358" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301358" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040d9e75f66d18aa9bafc5">Mitochondrial Neurogastrointestinal Encephalopathy Disease - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Mitochondrial Neurogastrointestinal Encephalopathy Disease - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:32:14-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CC9F7E0400C2100000000052D01D8&amp;ncbi_session=CE8CC9F7E040D9D1_1325SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1179%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1179&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1179/&amp;ncbi_pagename=Mitochondrial Neurogastrointestinal Encephalopathy Disease - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CC9F7E040D9D1_1325SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>